Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) announced today that it will provide one million NZ dollars in sponsorship towards the development of a clinical education centre at the new Auckland City Hospital. The centre will be named the Fisher & Paykel Healthcare Clinical Education Centre and will serve as a world-class regional facility for clinical education, training and conferences.
"We are delighted to have the opportunity to sponsor this important facility and to recognise our long-standing associations with Auckland Hospital, National Women's, Greenlane and Starship, which will shortly be on the one site at Auckland City Hospital in Grafton. Our relationship began more than 35 years ago, as much of the original clinical development of our world leading humidification technology took place at Auckland Hospital", commented Fisher & Paykel Healthcare's Chairman, Mr Gary Paykel.
The idea of a clinical education centre was discussed in the early stages of planning for the new hospital building, but there was no budget allocated for it.
The Auckland DHB Charitable Trust has been fundraising to develop the Centre. The chairman, Dr Richard Frith, said the Fisher & Paykel Healthcare sponsorship of one million dollars is the largest single contribution, and will enable tenders to go out shortly for complete fit-out. He said the Centre is expected to open in November, and already has a number of bookings for medical conferences.
The Fisher & Paykel Healthcare Clinical Education Centre, located on level 5 of the new hospital, will have a 220 seat auditorium with six meeting rooms for between 10 and 50 people. There will also be a library/reading room.
Dr Frith said it will have state-of-the-art audio visual and technical equipment including the potential for links to operating theatres, which will allow clinicians to watch and learn from surgical procedures taking place elsewhere in the hospital.
“Philanthropic support of the magnitude offered by Fisher & Paykel Healthcare is tremendously important to the enhancement of good patient care and medical education within the Auckland District Health Board,” he said.
Megan Richards: ADHB Communications Manager ; Tel: 021 804 122
Michael Daniell: CEO, Fisher & Paykel Healthcare ; Tel: + 64 9 5740161
Fisher & Paykel Healthcare to Sponsor Auckland Clinical Education Centre
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment